What does CUSIP 53619R102 represent in this 13F holders report?

CUSIP 53619R102 is the security identifier for LBIO - LION BIOTECHNOLOGIES INC - COM used to aggregate holder disclosures.

How many institutions held LBIO - LION BIOTECHNOLOGIES INC - COM in Q2 2016?

81 institutional investors reported LBIO - LION BIOTECHNOLOGIES INC - COM for Q2 2016. Use the holders table for investor-level position and value details.

LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / COM
Total 13F shares: 44,204,795
Share change: +7,704,712
Total reported value: $357,066,557
Put/Call ratio: 415%
Price per share: $8.10
Number of holders: 81
Value change: +$66,238,721
Number of buys: 50
Number of sells: 27

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP 53619R102:

Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q2 2016

As of 30 Jun 2016, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,204,795 shares. The largest 10 holders included FMR LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, ACUTA CAPITAL PARTNERS, LLC, Broadfin Capital, LLC, RS INVESTMENT MANAGEMENT CO LLC, BlackRock Fund Advisors, and VANGUARD GROUP INC. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.